『Episode 12: Rosavins — The Stress-Resilience Molecules from Rhodiola』のカバーアート

Episode 12: Rosavins — The Stress-Resilience Molecules from Rhodiola

Episode 12: Rosavins — The Stress-Resilience Molecules from Rhodiola

無料で聴く

ポッドキャストの詳細を見る

今ならプレミアムプランが3カ月 月額99円

2026年5月12日まで。4か月目以降は月額1,500円で自動更新します。

概要

What if your body could handle stress better—not by eliminating it, but by responding to it more intelligently?


In this episode, we break down rosavins, a group of powerful plant molecules found in Rhodiola rosea—an adaptogenic herb used for centuries in some of the harshest environments on Earth.


These molecules help the plant survive extreme cold, altitude, and environmental stress… and when we consume them, they may help us do the same.


We explore how rosavins interact with key biological systems, including:


• The HPA axis (your stress-response system)

Neurotransmitters like serotonin, dopamine, and norepinephrine

Mitochondrial energy production (ATP)

Cellular defense systems like antioxidant pathways


Backed by human clinical studies, Rhodiola extracts standardized for rosavins have been shown to support:


• Stress resilience and reduced burnout

• Mental clarity and cognitive performance

• Physical endurance and fatigue resistance

• Mood support in mild to moderate depression


You’ll also learn:


• What makes rosavins unique to Rhodiola

• How these molecules work at the cellular level

• Evidence-based dosing used in clinical studies

• Why adaptogens don’t force change—but help restore balance


In a world of chronic stress, these molecules represent something powerful:


Biochemical tools from nature that help the body adapt, recover, and perform.


Because at the end of the day…


New molecules = new signals = new you.


References

Panossian A., Wikman G.

Effects of adaptogens on the central nervous system and the molecular mechanisms associated with their stress-protective activity.

Pharmaceuticals. 2010.


Darbinyan V. et al.

Rhodiola rosea in stress-induced fatigue: A double-blind cross-over study of a standardized extract SHR-5.

Phytomedicine. 2000.


Olsson E. et al.

A randomized, double-blind, placebo-controlled study of Rhodiola rosea extract in patients with mild to moderate depression.

Nordic Journal of Psychiatry. 2009.


Panossian A., Wikman G.

Pharmacology of Rhodiola rosea.

Phytomedicine. 2010.


Spasov A. et al.

A double-blind placebo-controlled pilot study of Rhodiola rosea in students during an examination period.

Phytomedicine. 2000.

まだレビューはありません